Literature DB >> 17086189

Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death.

Vineet Bhandari1, Rayman Choo-Wing, Chun G Lee, Zhou Zhu, Jonathan H Nedrelow, Geoffrey L Chupp, Xucher Zhang, Michael A Matthay, Lorraine B Ware, Robert J Homer, Patty J Lee, Anke Geick, Antonin R de Fougerolles, Jack A Elias.   

Abstract

The angiogenic growth factor angiopoietin 2 (Ang2) destabilizes blood vessels, enhances vascular leak and induces vascular regression and endothelial cell apoptosis. We considered that Ang2 might be important in hyperoxic acute lung injury (ALI). Here we have characterized the responses in lungs induced by hyperoxia in wild-type and Ang2-/- mice or those given either recombinant Ang2 or short interfering RNA (siRNA) targeted to Ang2. During hyperoxia Ang2 expression is induced in lung epithelial cells, while hyperoxia-induced oxidant injury, cell death, inflammation, permeability alterations and mortality are ameliorated in Ang2-/- and siRNA-treated mice. Hyperoxia induces and activates the extrinsic and mitochondrial cell death pathways and activates initiator and effector caspases through Ang2-dependent pathways in vivo. Ang2 increases inflammation and cell death during hyperoxia in vivo and stimulates epithelial necrosis in hyperoxia in vitro. Ang2 in plasma and alveolar edema fluid is increased in adults with ALI and pulmonary edema. Tracheal Ang2 is also increased in neonates that develop bronchopulmonary dysplasia. Ang2 is thus a mediator of epithelial necrosis with an important role in hyperoxic ALI and pulmonary edema.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086189      PMCID: PMC2768268          DOI: 10.1038/nm1494

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  50 in total

1.  Tie-2 and angiopoietin-1 expression in human thyroid tumors.

Authors:  N Mitsutake; H Namba; K Takahara; K Ishigaki; J Ishigaki; H Ayabe; S Yamashita
Journal:  Thyroid       Date:  2002-02       Impact factor: 6.568

2.  Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury.

Authors:  Chuan Hua He; Aaron B Waxman; Chun Geun Lee; Holger Link; Morgan E Rabach; Bing Ma; Qingsheng Chen; Zhou Zhu; Mei Zhong; Keiko Nakayama; Keiichi I Nakayama; Robert Homer; Jack A Elias
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

3.  Interleukin-6-induced protection in hyperoxic acute lung injury.

Authors:  N S Ward; A B Waxman; R J Homer; L L Mantell; O Einarsson; Y Du; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  2000-05       Impact factor: 6.914

4.  The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome.

Authors:  J Pugin; G Verghese; M C Widmer; M A Matthay
Journal:  Crit Care Med       Date:  1999-02       Impact factor: 7.598

5.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Authors:  Ivan B Lobov; Peter C Brooks; Richard A Lang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

6.  Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury.

Authors:  Dimitrios Karmpaliotis; Ioanna Kosmidou; Edward P Ingenito; Kailin Hong; Atul Malhotra; Mary E Sunday; Kathleen J Haley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-09       Impact factor: 5.464

Review 7.  Angiopoietins in angiogenesis and beyond.

Authors:  Stelios Tsigkos; Micheal Koutsilieris; Andreas Papapetropoulos
Journal:  Expert Opin Investig Drugs       Date:  2003-06       Impact factor: 6.206

Review 8.  Pathogenesis of psoriatic arthritis.

Authors:  Allen P Anandarajah; Christopher T Ritchlin
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

9.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2.

Authors:  E Y Lin; A Orlofsky; M S Berger; M B Prystowsky
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

Review 10.  Angiopoietins in tumours: the angiogenic switch.

Authors:  Catherine R Tait; Pamela F Jones
Journal:  J Pathol       Date:  2004-09       Impact factor: 7.996

View more
  151 in total

1.  NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability.

Authors:  Narasaiah Kolliputi; Lakshmi Galam; Prasanna Tamarapu Parthasarathy; Srinivas M Tipparaju; Richard F Lockey
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

2.  Angiopoietin-2-driven vascular remodeling in airway inflammation.

Authors:  Sebastien P Tabruyn; Katharine Colton; Tohru Morisada; Jonas Fuxe; Stanley J Wiegand; Gavin Thurston; Anthony J Coyle; Jane Connor; Donald M McDonald
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

3.  Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: Mechanistic roles of antioxidant enzymes and RelB.

Authors:  Shaojie Zhang; Ananddeep Patel; Chun Chu; Weiwu Jiang; Lihua Wang; Stephen E Welty; Bhagavatula Moorthy; Binoy Shivanna
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-29       Impact factor: 4.219

4.  The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation.

Authors:  Katelyn E Milam; Samir M Parikh
Journal:  Tissue Barriers       Date:  2015-04-03

5.  Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Stephen Arias; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

Review 6.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

7.  Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.

Authors:  Ashish Agrawal; Michael A Matthay; Kirsten N Kangelaris; John Stein; Jeffrey C Chu; Brandon M Imp; Alfredo Cortez; Jason Abbott; Kathleen D Liu; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

8.  RNA interference as a potential therapeutic treatment for inflammation associated lung injury.

Authors:  Joanne Lomas-Neira; Chun-Shiang Chung; Alfred Ayala
Journal:  Int J Clin Exp Med       Date:  2008-02-25

9.  Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

Authors:  Michael A Matthay; Carolyn S Calfee; Hanjing Zhuo; B Taylor Thompson; Jennifer G Wilson; Joseph E Levitt; Angela J Rogers; Jeffrey E Gotts; Jeanine P Wiener-Kronish; Ednan K Bajwa; Michael P Donahoe; Bryan J McVerry; Luis A Ortiz; Matthew Exline; John W Christman; Jason Abbott; Kevin L Delucchi; Lizette Caballero; Melanie McMillan; David H McKenna; Kathleen D Liu
Journal:  Lancet Respir Med       Date:  2018-11-16       Impact factor: 30.700

10.  TREM-1 Attenuates RIPK3-mediated Necroptosis in Hyperoxia-induced Lung Injury in Neonatal Mice.

Authors:  Mansoor Ali Syed; Dilip Shah; Pragnya Das; Sture Andersson; Gloria Pryhuber; Vineet Bhandari
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.